Status:
COMPLETED
Impact of the Diagnosis of Celiac Disease
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Tampere University
Finnish Celiac Society
Conditions:
Celiac Disease
Eligibility:
All Genders
Brief Summary
The main purpose of this study is to assess the impact of the diagnosis of celiac disease on general health, healthcare resource utilization, quality of life and lifestyle. We hypothesize that diagnos...
Detailed Description
All new members with biopsy-proven celiac disease joining the Finnish Celiac Society will be categorized in three groups according to symptoms and signs leading to the diagnosis as classical symptoms,...
Eligibility Criteria
Inclusion
- diagnosis within one year
- biopsy-proven diagnosis
Exclusion
- Celiac disease diagnosis previously than within one year
- No biopsy-proven diagnosis
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT01145287
Start Date
February 1 2007
End Date
April 1 2016
Last Update
April 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Research Centre, University of Tampere, Tampere University Hospital
Tampere, Pirkanmaa, Finland, 33014